Product Images Neomycin And Polymyxin B Sulfates And Hydrocortisone Otic Suspension
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Neomycin And Polymyxin B Sulfates And Hydrocortisone Otic Suspension NDC 64980-448 by Rising Pharma Holdings, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a medication called Ototoxic Suspension, used for ear infections. The active ingredients are Neomycin and Polymyxin B Sulfate equivalent to 10,000 polymyxin B units, and Hydrocortisone. It is important to shake well before use, and is intended for use in the ear only. The dosage and precautions should be located in the accompanying package insert. The product is distributed by Rising Pharmaceuticals from a location in Saddie Brook, NJ.*
Neomycin B is a chemical compound where R is hydrogen and R' is either CH or NH. Neomycin C is a different chemical compound from Neomycin B where R' is CH and R is hydrogen.*
The text appears to be describing the chemical structure of Polymyxin B, a type of antibiotic that contains amino acids such as diaminobutyric acid (DAB) and is typically used to treat infections caused by Gram-negative bacteria. The text provides information about the specific arrangement of amino acids in the molecule, including the presence of certain side chains like CHy and L-Leu. However, without additional context, it is difficult to provide a complete description of the significance or function of these structural features.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.